CI
SLSN

CX Institutional’s Solesence Inc SLSN Stock Holding History

CX Institutional’s Portfolio SLSN Stock Details SLSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$1K – 1683
2025
Q4 		$1K Buy
+500
New +$1.35K ﹤0.01% 1515

Other funds holding SLSN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CX Institutional's SLSN Position: Q1 2026 in Review

CX Institutional sold out of Solesence Inc (SLSN) in Q1 2026, closing a stake of 500 shares — an estimated $1K sold.

CX Institutional first reported a position in SLSN in Q4 2025 and held it in 1 quarter. The position peaked at $1K in Q4 2025. 49 funds tracked by Wall St. Rank hold SLSN as of Q1 2026.

  • CX Institutional reported no remaining Solesence Inc position as of Q1 2026 after selling out during the quarter.
  • CX Institutional sold 500 Solesence Inc shares in Q1 2026, an estimated $1K.
  • CX Institutional first reported a position in Solesence Inc in Q4 2025 and held it in 1 quarter.
  • CX Institutional's Solesence Inc position peaked at $1K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Solesence Inc as of Q1 2026.

Based on CX Institutional's 13F filing for Q1 2026, filed 6 Apr 2026.